Copyright
©The Author(s) 2022.
World J Hepatol. Feb 27, 2022; 14(2): 456-463
Published online Feb 27, 2022. doi: 10.4254/wjh.v14.i2.456
Published online Feb 27, 2022. doi: 10.4254/wjh.v14.i2.456
ID | Ref. | Age (yr) | Sex | Preoperative HCV RNA (IU/mL) | HCV genotype | Rejection episode | Concomitant Issues | Immunosuppression | HCV clearance time |
1 | Neumann and Neuhaus[20], 2004 | 54 | M | + | 1b | 1 | HAT, retransplant | TAC, MMF, CS | 3 mo |
2 | Samonakis et al[21], 2005 | 48 | M | 250000 | 1a | 3 | Renal failure | TAC, AZA, CS | 75 mo |
3 | Samonakis et al[21], 2005 | 55 | M | 121000 | 4 | 3 | Renal failure | TAC, AZA, CS | 15 mo |
4 | Bhagat et al[7], 2008 | 43 | M | 564000 | NA | 3 | HIV/HAART | MP, TAC, MMF | 1 mo |
5 | Bhagat et al[7], 2008 | 44 | M | 450000 | NA | 3 | HIV/HAART | MP, TAC | 1 mo |
6 | Suneetha et al[22], 2008 | 69 | F | + | 3a | 3 | Renal failure/dialysis | MP, Il2a, CSA, CS | 12 yr |
7 | Weber and Trotter[23], 2009 | 53 | M | 2.5 million | 1a | 3 | - | TAC, CSA, MMF to CSA | 28 mo |
8 | Dale et al[24], 2009 | 32 | F | 3.2 million | NA | 1 | Dialysis/renal tx | Basiliximuab, TAC, MMF, CS | 5 mo |
9 | Haque et al[19], 2010 | 66 | F | + | 2a/2c | 3 | IVC thrombosis | TAC, MMF, CS | 11 mo |
10 | Seetharam et al[18], 2011 | 48 | M | 675000 | 1 | 0 | - | MP, MMF, CS | 2.25 mo |
11 | Gutiérrez-Moreno et al[26], 2012 | 38 | M | 2564 | 1 | 0 | HIV | CSA, MMF, CS | 5 mo |
12 | Chin et al[12], 2012 | 40 | M | 24 | 1a | 1 | Alcohol | Daclizumab, TAC, CS, MMF | 34 mo |
13 | Chin et al[12], 2012 | 41 | M | + | 1 | 0 | Alcohol | TAC, CS, AZA | 9 years |
14 | Elsiesy et al[25], 2015 | 32 | F | 65553 | 4 | 0 | AIH, DM | FK, CS, CSA, CS | 1 mo |
15 | Urzúa et al[27], 2015 | 51 | M | + | NA | 1 | Colon Cancer | CSA, MMF, TAC | 18 mo |
16 | Urzúa et al[27], 2015 | 48 | M | 280998 | 3a | 0 | D2M, alcohol | CSA, IL2a | 56 mo |
17 | Kogiso et al[28], 2015 | 50 | F | 19952 | 1 | NA | - | TAC, MMF, MP, CS | Approximately 3 mo |
18 | Tamaki et al[11], 2015 | 66 | M | 199526 | 1b | 0 | Sepsis | Rituximab, TAC, MMF, MP, CS | 5 mo |
19 | Tamaki et al[11], 2015 | 61 | M | 199 | 2 | Yes | Sepsis | TAC, MMF, MP, CS | 3.6 mo |
20 | Tamaki et al[11], 2015 | 55 | M | 125 | 1b | 0 | - | TAC, MMF, MP, CS | 5.8 mo |
21 | Tamaki et al[11], 2015 | 55 | M | 316227 | 1b | Yes | - | TAC, MMF, MP, CS | 0.5 mo |
22 | Our Case 1 | 57 | M | + | 1a | 2 | CMV infection | Sirolimus, MMF, CS | 15 yr |
23 | Our Case 2 | 64 | M | + | 1 | 0 | Donor HBV core + | TAC, MMF | 2 mo |
24 | Our Case 3 | 57 | M | + | 1a | 0 | Renal tx | TAC, MMF | 1 yr |
- Citation: Singh N, Ma M, Montano-Loza AJ, Bhanji RA. Learning from a rare phenomenon — spontaneous clearance of chronic hepatitis C virus post-liver transplant: A case report. World J Hepatol 2022; 14(2): 456-463
- URL: https://www.wjgnet.com/1948-5182/full/v14/i2/456.htm
- DOI: https://dx.doi.org/10.4254/wjh.v14.i2.456